Seiji Isonishi
- Reproductive Medicine top 0.5%
- Ovarian cancer diagnosis and treatment 36
- Endometriosis Research and Treatment 5
- Biological Psychiatry top 2%
- Obstetrics and Gynecology top 2%
- Endometrial and Cervical Cancer Treatments 10
- Oncology top 5%
- Cancer Treatment and Pharmacology 10
- Drug Transport and Resistance Mechanisms 7
- Metal complexes synthesis and properties 7
- Behavioral Neuroscience top 5%
-
- Intraperitoneal and Appendiceal Malignancies 13
-
- PI3K/AKT/mTOR signaling in cancer 6
Seiji Isonishi
75 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 99
- Reproductive Medicine 969
- Biological Psychiatry 199
- Obstetrics and Gynecology 367
- Oncology 799
- Behavioral Neuroscience 76
Countries citing papers authored by Seiji Isonishi
This map shows the geographic impact of Seiji Isonishi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seiji Isonishi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seiji Isonishi more than expected).
Fields of papers citing papers by Seiji Isonishi
This network shows the impact of papers produced by Seiji Isonishi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seiji Isonishi. The network helps show where Seiji Isonishi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Seiji Isonishi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 16 | |
| 2 | 2018 | 18 | |
| 3 | 2015 | 2 | |
| 4 | 2014 | 1 | |
| 5 | 2014 | 22 | |
| 6 | 2012 | 5 | |
| 7 | 2010 | 1 | |
| 8 | Favourable prognosis with modified dosing of docetaxel and cisplatin in Japanese patients with ovarian cancer. | 2009 | 5 |
| 9 | Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trialbreakdown → | 2009 | 502 |
| 10 | 2004 | 14 | |
| 11 | 2003 | 5 | |
| 12 | 2001 | 107 | |
| 13 | 2000 | 6 | |
| 14 | 2000 | 29 | |
| 15 | 2000 | 31 | |
| 16 | 1999 | 25 | |
| 17 | 1992 | 21 | |
| 18 | 1990 | 9 | |
| 19 | 1989 | 6 | |
| 20 | 1988 | 7 |
About Seiji Isonishi
Seiji Isonishi is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Oncology, having authored 80 papers that have together received 2.2k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (36 papers), Intraperitoneal and Appendiceal Malignancies (13 papers), Endometrial and Cervical Cancer Treatments (10 papers), Cancer Treatment and Pharmacology (10 papers), Drug Transport and Resistance Mechanisms (7 papers), Metal complexes synthesis and properties (7 papers), PI3K/AKT/mTOR signaling in cancer (6 papers) and Endometriosis Research and Treatment (5 papers). The work is most often cited by research in Reproductive Medicine (969 citations), Biological Psychiatry (199 citations) and Obstetrics and Gynecology (367 citations). Seiji Isonishi has collaborated with scholars based in Japan, United States and Italy. Frequent co-authors include Kazunori Ochiai, Makoto Yasuda, Toru Sugiyama, Daisuke Aoki, Toshiko Jobo, Eizo Kimura, Fumiaki Takahashi, Noriyuki Katsumata, Shoji Kodama and Aikou Okamoto. Their work appears in journals such as The Lancet, Journal of Biological Chemistry and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.